These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 28154184
21. Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells. Sarif Z, Tolksdorf B, Fechner H, Eberle J. Mol Carcinog; 2020 Nov; 59(11):1256-1268. PubMed ID: 32885857 [Abstract] [Full Text] [Related]
22. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926 [Abstract] [Full Text] [Related]
23. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH, Gores GJ. Cancer Res; 2004 May 15; 64(10):3517-24. PubMed ID: 15150106 [Abstract] [Full Text] [Related]
24. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism. Liu S, Gao M, Wang X, Ding S, Lv J, Gao D, Wang Z, Niu Z. Oncotarget; 2016 Nov 29; 7(48):79141-79153. PubMed ID: 27816967 [Abstract] [Full Text] [Related]
25. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1. Jang JH, Lee TJ, Yang ES, Min do S, Kim YH, Kim SH, Choi YH, Park JW, Choi KS, Kwon TK. Exp Cell Res; 2010 Aug 01; 316(13):2194-203. PubMed ID: 20451517 [Abstract] [Full Text] [Related]
26. ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells. Li J, Chen Y, Wan J, Liu X, Yu C, Li W. Br J Pharmacol; 2014 Jul 01; 171(13):3182-95. PubMed ID: 24571452 [Abstract] [Full Text] [Related]
27. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis. Rohde K, Kleinesudeik L, Roesler S, Löwe O, Heidler J, Schröder K, Wittig I, Dröse S, Fulda S. Cell Death Differ; 2017 Jan 01; 24(1):83-97. PubMed ID: 27834956 [Abstract] [Full Text] [Related]
28. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma. Xargay-Torrent S, López-Guerra M, Montraveta A, Saborit-Villarroya I, Rosich L, Navarro A, Pérez-Galán P, Roué G, Campo E, Colomer D. Clin Cancer Res; 2013 Feb 01; 19(3):586-97. PubMed ID: 23231952 [Abstract] [Full Text] [Related]
29. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Park SS, Jwa E, Shin SH, Ju EJ, Park I, Pak JH, Hwang JJ, Cho DH, Kim BM, Kim SB, Lee JS, Song SY, Jeong SY, Choi EK. Int J Biochem Cell Biol; 2017 Feb 01; 83():47-55. PubMed ID: 27923747 [Abstract] [Full Text] [Related]
33. Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells. Kim MJ, Lee KH, Lee SJ. FEBS J; 2008 May 01; 275(9):2096-108. PubMed ID: 18373696 [Abstract] [Full Text] [Related]
34. Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Brooks AD, Jacobsen KM, Li W, Shanker A, Sayers TJ. Mol Cancer Res; 2010 May 01; 8(5):729-38. PubMed ID: 20442297 [Abstract] [Full Text] [Related]
35. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Hu H, Jiang C, Schuster T, Li GX, Daniel PT, Lü J. Mol Cancer Ther; 2006 Jul 01; 5(7):1873-82. PubMed ID: 16891474 [Abstract] [Full Text] [Related]
36. Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis. Wei R, Zhu G, Jia N, Yang W. Cell Biochem Biophys; 2015 May 01; 72(1):157-64. PubMed ID: 25539708 [Abstract] [Full Text] [Related]
37. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway. Jelínková I, Šafaříková B, Vondálová Blanářová O, Skender B, Hofmanová J, Sova P, Moyer MP, Kozubík A, Kolář Z, Ehrmann J, Hyršlová Vaculová A. Biochem Pharmacol; 2014 Dec 01; 92(3):415-24. PubMed ID: 25285768 [Abstract] [Full Text] [Related]
38. Potent proapoptotic actions of dihydroartemisinin in gemcitabine-resistant A549 cells. Zhao C, Qin G, Gao W, Chen J, Liu H, Xi G, Li T, Wu S, Chen T. Cell Signal; 2014 Oct 01; 26(10):2223-33. PubMed ID: 25018064 [Abstract] [Full Text] [Related]
39. Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells. Han MA, Min KJ, Woo SM, Seo BR, Kwon TK. Oncotarget; 2016 Oct 04; 7(40):65707-65720. PubMed ID: 27582546 [Abstract] [Full Text] [Related]
40. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Chen S, Dai Y, Harada H, Dent P, Grant S. Cancer Res; 2007 Jan 15; 67(2):782-91. PubMed ID: 17234790 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]